Scientific Advisory Board
Fred H. Gage PhD is the Adler Professor in the Laboratory of Genetics at the Salk Institute. His laboratory discovered neurogenesis in the adult human brain in 1998. Since then, the Gage lab has concentrated on the adult central nervous system, its plasticity and adaptability, and functional implications in a wide range of neurological disorders. Dr. Gage is an esteemed member of the international neuroscience community and has won many awards. Previously, he was the President of the Society for Neuroscience (SfN) and the International Society for Stem Cell Research (ISSCR). He is a member of the National Academy of Sciences and American Academy of Arts and Sciences.
Industry Advisory Board
Ian J. Massey PhD is a veteran neuroscience drug development executive. Dr. Massey was the Co-Founder, President, and CEO of Synosia Therapeutics that was focused on the development of novel therapeutics for the treatment of neurological and psychiatric diseases. In 2011, Synosia was acquired by Finnish drug development company Biotie Therapies Corporation. Prior to Synosia, he was the Head of Research and Preclinical Development for Roche in Palo Alto and, prior to this, he was the Head and Vice President of the Neurobiology Business Unit at Roche. Before joining Roche, Dr. Massey spent almost 20 years with Syntex in a variety of leadership positions. Dr. Massey has contributed to the discovery, preclinical, and early clinical development of more than 20 chemical entities that progressed to clinical (Phase II Proof of Concept and beyond) studies.
Rodney Turner is the CEO of AYOXXA Biosystems GmbH. He is an accomplished serial entrepreneur, corporate business development executive, and leader in the global life sciences industry. Previously, he was the Vice President of Corporate Business Development at Life Technologies and Fluidigm. He has been an active member of the biotech startup community, advising startup companies regarding their corporate strategies.
firstname.lastname@example.org | © 2020-2021, all rights reserved